137 related articles for article (PubMed ID: 29888106)
1. Centromere protein U facilitates metastasis of ovarian cancer cells by targeting high mobility group box 2 expression.
Li H; Zhang H; Wang Y
Am J Cancer Res; 2018; 8(5):835-851. PubMed ID: 29888106
[TBL] [Abstract][Full Text] [Related]
2. Centromere protein U (CENPU) promotes gastric cancer cell proliferation and glycolysis by regulating high mobility group box 2 (HMGB2).
Deng T; Jiang X; He Z; Cai M; Chen C; Xu Z
Bioengineered; 2021 Dec; 12(2):10194-10202. PubMed ID: 34872447
[TBL] [Abstract][Full Text] [Related]
3. Centromere protein U promotes cell proliferation, migration and invasion involving Wnt/β-catenin signaling pathway in non-small cell lung cancer.
Zhang Q; Li YD; Zhang SX; Shi YY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7768-7777. PubMed ID: 30536323
[TBL] [Abstract][Full Text] [Related]
4. A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma.
Liu Y; Yao Y; Liao B; Zhang H; Yang Z; Xia P; Jiang X; Ma W; Wu X; Mei C; Wang G; Gao M; Xu K; GongYe X; Cheng Z; Jiang P; Chen X; Yuan Y
Int J Biol Sci; 2022; 18(10):4071-4087. PubMed ID: 35844791
[TBL] [Abstract][Full Text] [Related]
5. [Centromere protein U is highly expressed in colorectal cancer and associated with a poor long-term prognosis].
Zhang X; Yang Z; Hu Q; Zuo L; Song X; Geng Z; Li J; Wang Y; Ge S; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1198-1204. PubMed ID: 36073219
[TBL] [Abstract][Full Text] [Related]
6. Centromere protein U is a potential target for gene therapy of human bladder cancer.
Wang S; Liu B; Zhang J; Sun W; Dai C; Sun W; Li Q
Oncol Rep; 2017 Aug; 38(2):735-744. PubMed ID: 28677729
[TBL] [Abstract][Full Text] [Related]
7. Reduced CENPU expression inhibits lung adenocarcinoma cell proliferation and migration through PI3K/AKT signaling.
Li J; Wang ZG; Pang LB; Zhang RH; Wang YY
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1077-1084. PubMed ID: 30849291
[TBL] [Abstract][Full Text] [Related]
8. The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.
Lin SY; Lv YB; Mao GX; Chen XJ; Peng F
Oncol Lett; 2018 Nov; 16(5):6721-6728. PubMed ID: 30405814
[TBL] [Abstract][Full Text] [Related]
9. Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.
Wang X; Chen D; Gao J; Long H; Zha H; Zhang A; Shu C; Zhou L; Yang F; Zhu B; Wu W
Cancer Manag Res; 2018; 10():6971-6984. PubMed ID: 30588102
[TBL] [Abstract][Full Text] [Related]
10. Centromere protein U enhances the progression of bladder cancer by promoting mitochondrial ribosomal protein s28 expression.
Liu BB; Ma T; Sun W; Gao WY; Liu JM; Li LQ; Li WY; Wang S; Guo YY
Korean J Physiol Pharmacol; 2021 Mar; 25(2):119-129. PubMed ID: 33602882
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the performance of polo-like kinase 1 in triple-negative breast cancer progression according to the centromere protein U-phosphorylation pathway.
Zhao S; Geng Y; Cao L; Yang Q; Pan T; Zhou D; Liu J; Shi Z; Zhang J
Am J Cancer Res; 2021; 11(5):2142-2158. PubMed ID: 34094674
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CST4 promotes gastric cancer aggressiveness by activating the ELFN2 signaling pathway.
Zhang YQ; Zhang JJ; Song HJ; Li DW
Am J Cancer Res; 2017; 7(11):2290-2304. PubMed ID: 29218251
[TBL] [Abstract][Full Text] [Related]
13. Short communication: A splice site mutation in CENPU is associated with recessive embryonic lethality in Holstein cattle.
Hozé C; Escouflaire C; Mesbah-Uddin M; Barbat A; Boussaha M; Deloche MC; Boichard D; Fritz S; Capitan A
J Dairy Sci; 2020 Jan; 103(1):607-612. PubMed ID: 31733857
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of golgi membrane protein 1 promotes non-small-cell carcinoma aggressiveness by regulating the matrix metallopeptidase 13.
Aruna ; Li LM
Am J Cancer Res; 2018; 8(3):551-565. PubMed ID: 29637008
[TBL] [Abstract][Full Text] [Related]
15. Identification of HRAS as cancer-promoting gene in gastric carcinoma cell aggressiveness.
Wu XY; Liu WT; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G
Am J Cancer Res; 2016; 6(9):1935-1948. PubMed ID: 27725900
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 2 promoted proliferation of cervical cancer cells by activating AKT signaling pathway.
Zhang P; Lu Y; Gao S
J Cell Biochem; 2019 Oct; 120(10):17345-17353. PubMed ID: 31209930
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1.
Wang W; Ren F; Wu Q; Jiang D; Li H; Peng Z; Wang J; Shi H
Biochem Biophys Res Commun; 2014 Jul; 449(4):432-7. PubMed ID: 24858688
[TBL] [Abstract][Full Text] [Related]
19. HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome.
Cui G; Cai F; Ding Z; Gao L
Hum Pathol; 2019 Feb; 84():133-141. PubMed ID: 30296520
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4.
Xi J; Feng J; Zeng S
Am J Cancer Res; 2017; 7(11):2180-2189. PubMed ID: 29218242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
